Carboxyamidotriazole exerts anti-inflammatory activity in lipopolysaccharide-induced RAW264.7 macrophages by inhibiting NF-κB and MAPKs pathways

Carboxyamidotriazole (CAI), originally developed as a non-cytotoxic anti-cancer drug, was shown to have anti-inflammatory activity according to recent studies in a number of animal models of inflammation. However, its mechanism of action has not been characterized. Therefore, the present study was p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Shan, Duan, Mengyuan, Guo, Zehao, Zhou, Yongting, Wu, Danwei, Zhang, Xiaojuan, Wang, Yicheng, Ye, Caiying, Ju, Rui, Li, Juan, Zhang, Dechang, Zhu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388320/
https://www.ncbi.nlm.nih.gov/pubmed/32742379
http://dx.doi.org/10.3892/etm.2020.8889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388320/
https://www.ncbi.nlm.nih.gov/pubmed/32742379
http://dx.doi.org/10.3892/etm.2020.8889

Ejemplares similares